Stock listing

Novavax, Inc.

Selected listing: NVAX · BIVA · MXN · MX

Novavax, Inc. (BIVA:NVAX), Health Technology. Latest release Sep 2, 2026: Novavax to Participate in September Investor Conferences.

NVAX:BIVAMXNMXUpdated October 2, 2026

Ticker: BIVA:NVAX
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: BIVA
Currency: MXN

About Novavax, Inc.

Novavax, Inc. is a publicly traded company listed under the ticker NVAX, operating in the American market. Novavax focuses on developing innovative vaccines to address various infectious diseases.

Latest news from Novavax, Inc.

Novavax to Participate in September Investor Conferences

September 2, 2026

Novavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season

August 28, 2026

Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights

August 6, 2026

Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026

July 30, 2026

Novavax to Participate in 2026 Jefferies Global Healthcare Conference

June 1, 2026

All Novavax, Inc. news →

Events

Replays

Novavax, Inc. (NVAX) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 08:30 AM ET
Watch
Novavax, Inc. (NVAX) Q1 2026 Earnings Call
Wed, May 06, 2026 · 08:30 AM ET
Watch
Novavax, Inc. (NVAX) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 08:30 AM ET
Watch

Research Novavax, Inc.

Novavax, Inc. company profile

View the public company page for Novavax, Inc. on 6ix.

Novavax, Inc. news

Read company news and market updates connected to Novavax, Inc..

Novavax, Inc. investor events

Find investor webinars, events, and replay context for Novavax, Inc..